[What is the benefit of the new AT1 receptor antagonists?].
Unger
T
T
Pharmakologischen Instituts der Universität Kiel.
D000803:Angiotensin I / Q000037:antagonists & inhibitors* / Q000502:physiology; D057911:Angiotensin Receptor Antagonists; D000818:Animals; D000959:Antihypertensive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006439:Hemodynamics / Q000187:drug effects / Q000502:physiology; D006801:Humans; D006978:Hypertension, Renovascular / Q000188:drug therapy*; D011945:Receptors, Angiotensin / Q000502:physiology
D057911:Angiotensin Receptor Antagonists; D000959:Antihypertensive Agents; D011945:Receptors, Angiotensin; D000803:Angiotensin I